Antimicrobial Resistance Surveillance Market
Report ID: SQMIG35G2347
Report ID: SQMIG35G2347
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35G2347 |
Region:
Global |
Published Date: December, 2025
Pages:
191
|Tables:
92
|Figures:
69
Global Antimicrobial Resistance Surveillance Market size was valued at USD 6.23 Billion in 2024 and is poised to grow from USD 6.58 Billion in 2025 to USD 10.17 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026–2033).
The increasing rates of antimicrobial resistance is amplifying global health risks, motivating governments, health agencies, and intergovernmental organizations to prioritize surveillance systems for antimicrobial resistance. There is a growth need for timely data collection, pathogen monitoring, and resistance-pattern analysis as drug-resistant infections continue to increase across regions, creating considerable need for advanced antimicrobial resistance surveillance systems to enable rapid detection and informed clinical decision-making. The enhanced focus on public health preparedness and infection control rationale is fundamentally driving to market growth. At the same time, regulatory objectives and international action plans, such as the World Health Organization Global Antimicrobial Resistance Surveillance System and United States Center for Disease Control and Prevention initiative are mandating improved surveillance capabilities. For example, many countries are investing in laboratory infrastructure, integrated data systems, and real-time data reporting systems, to support surveying capabilities. Healthcare providers are using these systems to help comply with infection control processes, intending to guide antimicrobial stewardship and decrease healthcare-associated infections. Regulated and institutional focus will enable a faster deployment of antimicrobial resistance surveillance systems around the world, creating a solid platform for further market growth.
How is Artificial Intelligence Transforming Precision in Antimicrobial Resistance Surveillance?
Artificial Intelligence revolutionizes the global antimicrobial resistance surveillance market by improving detection accuracy, accelerating responsiveness, and fine-tuning predictive analytics. Artificial Intelligence allows public health agencies and health care organizations to process large-scale microbiological datasets, genomic datasets, and epidemiological datasets in real time, enabling premature identification of resistance patterns, automated outbreak tracking and more accurate risk assessments of the same.
Additionally, Artificial Intelligence-based algorithms can take observations from hospital records, lab test records, and prescriptions to identify slight changes in the antimicrobial resistance vain that could be overlooked, especially in low-resource regions and highly burdened populations. Institutions are also using machine learning modelling to make basic predictions of multi-drug resistant organism emergence to focus their surveillance work. For instance, in April 2025, a consortium led by the European Centre for Disease Prevention and Control worked with leading firms in artificial intelligence research to establish an advanced surveillance system to find resistance signals from clinical reporting across Europe, incorporating natural language processing and predictive modelling into their process.
Market snapshot - 2026-2033
Global Market Size
USD 5.9 Billion
Largest Segment
Service
Fastest Growth
Software
Growth Rate
5.6% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Antimicrobial Resistance Surveillance Market is segmented by Component, Technology, End User and region. Based on Component, the market is segmented into Software, Hardware and Services. Based on Technology, the market is segmented into Phenotypic Methods, Genotypic Methods and Bioinformatics Solutions. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
According to the global antimicrobial resistance surveillance market forecast, the services segment currently dominates the market in terms of revenue share. This dominance is mainly due to the demand for the consults, training, installation, and maintenance related to the implementation and use of surveillance systems. As healthcare organizations and public health departments expand their data collection efforts, the capacity of service providers to ensure regulatory compliance, standardization of data, and real-time monitoring continues to increase. All services will be needed to facilitate interoperability across the diverse jurisdictions of healthcare and to support the long-term sustainable use of systems.
Software will be the fastest growing segment in the component category. The demands for centralized data platforms, automated reporting, real-time analytics, and tracking of resistance trends and use in clinical decision-making, and ease of information exchange among laboratories, hospitals, and health agencies, is driving demand for sophisticated software. All these factors combined, makes it an essential part for next generation antimicrobial resistance surveillance programs.
Phenotypic methods are the largest technology segment in the global antimicrobial resistance surveillance market. Phenotypic methods are clinically significant, regulatory accepted, and routinely used in public health, hospitals and diagnostic labs for operational accuracy. While the turnaround time is longer than newer tools, and therefore not as ideal, phenotypic technologies can predict useful information about antimicrobial action and provide useful operational treatment protocols and/or antimicrobial stewardship programs.
Genotypic methods will be the fastest growing technology segment as the amount of need for rapid resistance testing tools with high-throughput detection continues to increase. Genotypic methods provide a faster and more accurate result in outbreak and early-intervention scenarios. As sequencing becomes affordable and accessible, genotypic methods are being adopted at increasing pace in research institutions and public health institutions.
To get detailed segments analysis, Request a Free Sample Report
According to the global antimicrobial resistance surveillance market analysis, North America leads in the market due to its advanced healthcare infrastructure, extensive research investments, and strong public health surveillance systems. The region benefits from national programs like the CDC’s Antibiotic Resistance Solutions Initiative and collaborations between federal agencies, hospitals, and diagnostics companies. The presence of well-established diagnostic laboratories, electronic health records, and supportive regulatory policies positions North America as the most mature and dominant regional market.
The United States, with federal funding, biotechnology innovations, and integrated surveillance from national agencies (i.e., surveillance registry, the National Healthcare Safety Network [NHSN]), is the largest player in North America’s AMR surveillance market, and public-private partnerships have stimulated research support for rapid diagnostics and mapping of AMR. The U.S. is the market leader in both new technological developments and the implementation of strategic action, which maintains the prominence of the U.S.'s position at the forefront of the AMR landscape.
Canada’s AMR surveillance market is experiencing steady growth, supported by national strategies such as the Pan-Canadian Framework for Action on AMR and antimicrobial use. The approach of 'One Health' and improved data integration and laboratory modernization is also continuing to position Canada as a leader in the AMR surveillance market. Increased attention on rural and remote health care settings, and the influence of collaborative engagement in academic research, provide Canada potential for growth within this market.
Asia Pacific is the fastest-growing region in the antimicrobial resistance surveillance market, driven by rising antibiotic misuse, high infectious disease burden, and increasing government focus on healthcare modernization. International support from WHO and global health initiatives is also fostering capacity-building in laboratories and data reporting systems. Rapid urbanization, dense population centers, and cross-border health risks further underscore the need for robust AMR surveillance in Asia Pacific.
Japan is a crucial player in the Asia Pacific AMR surveillance market, owing to its robust regulatory framework and strong government interest in the area. The country initiated the National Action Plan on Antimicrobial Resistance as called for by the WHO, with an emphasis on monitoring, diagnostics, and stewardship. To expand capacity for AMR and resistance mapping, as well as the development of point-of-care diagnostics in response to AMR, Japan has an advanced collaboration among academic institutions, research universities, and biotech firms. This activity begins to position Japan as an innovative leader in AMR surveillance in the Asia Pacific region.
South Korea has been positioning itself as a strong AMR surveillance player by investing heavily in digital healthcare technologies and building centralized national databases. The central core of South Korea's strength in AMR surveillance is due to strong partnerships between hospitals, research universities, and key future-focused government ministries. There have even been AI-enabled tools and genome-based surveillance investigations developed inside hospitals. All these developments have made South Korea a dynamic and rapidly emerging source of AMR innovation in the Asia Pacific region.
Europe’s antimicrobial resistance surveillance market is expanding steadily, backed by robust public health networks, regulatory mandates, and transnational collaboration. EU funding, national action plans, and shared data frameworks enable timely detection and response to resistance patterns. Europe’s emphasis on data transparency, inter-country coordination, and responsible antimicrobial use is reinforcing its influence in the global AMR surveillance ecosystem.
Germany leads in the European AMR surveillance market as a result of its national strategy, strong lab systems and institutional support. Coordination between Federal and State health agencies yields systematic data collection and assessment of public health risk. Germany also invests in microbiology R&D and supports the digital transformation of public health infrastructure, making it a prominent leader in the region.
France is pivotal to Europe’s AMR surveillance initiatives through its organizations, including Santé Publique France and the French National Observatory for Epidemiology of Bacterial Resistance. France is actively engaged in international initiatives and EU funded research projects that promote harmonization of standards. Along with its well develop data infrastructure and public health advocacy, France continues to build its market presence.
Italy is gaining prominence in the European AMR surveillance market and is benefitting from its National Plan to Combat AMR (PNCAR). Collaboration with EU agencies and investments to strengthen digital epidemiology will likely improve Italy's monitoring capabilities and contribute to regional efforts.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Global Burden of Antimicrobial Resistance
Supportive Government Policies and International Collaborations
High Implementation Costs and Infrastructure Limitations
Data Fragmentation and Standardization Challenges
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global antimicrobial resistance surveillance industry is shaped by continuous advancements in diagnostic technologies, strategic partnerships, and global health investments. Key players in the market include Thermo Fisher Scientific, bioMérieux, BD (Becton, Dickinson and Company), Roche Diagnostics, and OpGen. For instance, bioMérieux is improving surveillance capability by adding molecular diagnostics to public health networks, and BD is investing in digital health capabilities that enable streamlined antimicrobial susceptibility testing and reporting.
Innovative startups are also looking to enter the market using artificial intelligence, cloud-based platforms, and big data analytics for real-time resistance tracking and outbreak prediction. Many of these companies work with regional health systems and research institutions as they can provide cheaper, scalable solutions. Their agility allows them to rapidly respond to localized resistance threats, creating competitive momentum and allowing them to push legacy diagnostic companies towards innovation.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global antimicrobial resistance surveillance market is expanding rapidly due to the rising burden of drug-resistant infections, increasing international policy mandates, and the integration of advanced technologies such as artificial intelligence and genomic surveillance. Healthcare organizations and public health authorities are pouring a lot of money into real-time data platforms, predictive analytics, and decentralized diagnostic technologies to enhance their ability to detect, report, and respond.
Regional growth is being facilitated by thriving markets in North America, Europe, and Asia-Pacific, which are improving their infrastructure, regulatory framework, and collaborative work. While challenges are facing the market, such as high implementation costs, workforce capacity challenges, and data standardization barriers, innovators and public-private partnerships are bolstering sustained market enthusiasm.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 6.23 Billion |
| Market size value in 2033 | USD 10.17 Billion |
| Growth Rate | 5.6% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Antimicrobial Resistance Surveillance Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antimicrobial Resistance Surveillance Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antimicrobial Resistance Surveillance Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Antimicrobial Resistance Surveillance Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
